Please login to the form below

Not currently logged in
Email:
Password:

Nigel Brooksby joins Health Information as deputy chair

Chair of UK Life Sciences Council adds pharma experience to patient information organisation

Nigel Brooksby has been appointed deputy chair at Health Information, a UK-based company that aims to provide and circulate patient information to improve compliance.

Brooksby, who is also currently chair of the UK Life Sciences Council, brings almost 40 years of experience in the pharma industry to the firm, which has recently secured funding from MVM Life Science Partners.

Other current positions currently held by Brooksby include board advisor at Doctors.net.uk, board strategic advisor at Healthcare at Home, director at Novocta Biosystems and advisor to the Wellcome Trust.

Previously, he was chair and MD at Sanofi UK and president of the UK's Association of the British Pharmaceutical Industry (ABPI).

Commenting on his new role, Brooksby said he was interested in the benefits that the improved provision of information could have on patient compliance.

He said: “There is a real need for patients to understand their conditions and medicines better, and Health Information has helped millions of patients to do this. I am looking forward to the opportunity to help develop this success further.”

Dr Grace Lomax, co-founder of Health Information, said “I am thrilled that Nigel is joining us.  His experience in the pharmaceutical industry will enable us to support more patients, and to fortify our leading position in the UK market.”

20th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...